Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

Alpha-methylacyl-CoA racemase (AMACR) is an enzyme playing an important role in the beta-oxidation of branched-chain fatty acids and fatty acid derivatives. High expression levels of AMACR have been described in various cancers, including prostate cancer, colorectal cancer and kidney cancer. Because...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Honma, Ichiya, Torigoe, Toshihiko, Hirohashi, Yoshihiko, Kitamura, Hiroshi, Sato, Eiji, Masumori, Naoya, Tamura, Yasuaki, Tsukamoto, Taiji, Sato, Noriyuki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2797764/
https://ncbi.nlm.nih.gov/pubmed/20003233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-7-103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados